PUBLISHER: Grand View Research | PRODUCT CODE: 1529778

PUBLISHER: Grand View Research | PRODUCT CODE: 1529778

Targeted Protein Degradation Market Size, Share & Trends Analysis Report By Type (PROTAC, LYTACs), By Application (Drug Discovery), By End Use (Hospitals And Clinical Laboratories), By Region, And Segment Forecasts, 2024 - 2030

PUBLISHED: July 16, 2024

PAGES: 120 Pages

DELIVERY TIME: 2-10 business days

ADD TO COMPARE

SELECT AN OPTION

List of Tables

Targeted Protein Degradation Market Trends

The global targeted protein degradation market size was estimated at USD 452.8 million in 2023 and is expected to expand at a CAGR of 20.72% from 2024 to 2030. The constantly growing frequency of chronic disease conditions such as cancer and neurodegenerative diseases, along with changing lifestyles and increasing healthcare spending, are accelerating the market growth. The high prevalence of these diseases creates a strong demand for novel treatment options, driving market growth. For Instance, data from the World Health Organization (WHO) indicates that in 2022, around 20 million individuals were newly diagnosed with cancer, and there were 9.7 million cancer-related deaths. It's estimated that 53.5 million people were living with cancer within five years after receiving their diagnosis.

The expanding number of research and development activities in this field provides significant opportunities for the market to grow. For instance, in December 2023, the Austrian Science Fund (FWF) approved the Special Research Program (SFB) in Targeted Protein Degradation for a second funding period of another four years. The SFB in Targeted protein degradation is a research initiative focusing on understanding and developing methods to target specific proteins for cell degradation. This program aims to advance the field of targeted protein degradation, which has gained significant attention in recent years due to its potential applications in drug discovery and therapeutic interventions.

The supportive regulatory environment, particularly the streamlined approval processes by agencies such as the FDA and EMA, has played a crucial role in accelerating the adoption of TPD-based therapies. The TPD market is driven by rapid advancements in the underlying technologies. The development of innovative approaches, such as proteolysis-targeting chimeras (PROTACs), molecular glues, and lysosome-targeting chimaeras (LYTACs), has expanded TPD's capabilities to selectively eliminate disease-causing proteins. These technological breakthroughs have opened up new avenues for targeting previously undruggable proteins, driving the growth of the TPD market.

The increasing recognition of the therapeutic potential of targeted protein degradation in addressing previously undruggable targets is a key driver for the targeted protein degradation market. Traditional approaches often struggle with proteins that are difficult to modulate, but technologies such as PROTACs (proteolysis-targeting chimeras) provide a favorable solution by promoting the degradation of disease-causing proteins. This method has shown considerable promise in treating conditions such as cancer and neurodegenerative disorders, sparking a surge in research and investment in this area. The National Institute of Health highlights PROTACs as a leading drug development technology in recent years. The increasing success in preclinical and early-phase clinical trials drives pharmaceutical and biotech companies to integrate targeted protein degradation into their pipelines, recognizing its potential to transform therapeutic strategies.

Global Targeted Protein Degradation Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global targeted protein degradation market report based on type, application, end use, and region.

Type Outlook (Revenue, USD Million, 2018 - 2030)
PROTAC
Molecular Glues
LYTACs
Others
Application Outlook (Revenue, USD Million, 2018 - 2030)
Drug Discovery
Therapy Development

Cancer

Neurology

Infectious Diseases

Cardiovascular Diseases

Others

End Use Outlook (Revenue, USD Million, 2018 - 2030)
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Hospitals & Clinical Laboratories
Others
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America

U.S.

Canada

Mexico

Europe

Germany

France

Italy

Spain

Denmark

Sweden

Norway

Asia Pacific

China

Japan

India

South Korea

Australia

Thailand

Latin America

Brazil

Argentina

South Africa

Saudi Arabia

UAE

Kuwait

Product Code: GVR-4-68040-351-3

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Market Definitions
- 1.2.1. Type Segment
- 1.2.2. Application Segment
- 1.2.3. End-Use Segment
1.3. Information analysis
- 1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
- 1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape

Chapter 3. Targeted Protein Degradation Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
- 3.2.1. Market driver analysis
  - 3.2.1.1. Growing frequency of chronic diseases
  - 3.2.1.2. Research and development activities
  - 3.2.1.3. Increasing recognition of the therapeutic potential of targeted protein degradation
- 3.2.2. Market restraint analysis
  - 3.2.2.1. High cost
  - 3.2.2.2. Stringent regulations associated with approvals for novel TPD based therapies
3.3. Targeted Protein Degradation Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.2. PESTEL Analysis
- 3.3.3. COVID-19 Impact Analysis

Chapter 4. Targeted Protein Degradation Market: Type Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Global Targeted Protein Degradation Market Type Movement Analysis
4.3. Global Targeted Protein Degradation Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. PROTAC
- 4.4.1. PROTAC market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Molecular Glues
- 4.5.1. Molecular Glues market estimates and forecasts 2018 to 2030 (USD Million)
4.6. LYTACs
- 4.6.1. LYTACs market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Others
- 4.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Targeted Protein Degradation Market: Application Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Global Targeted Protein Degradation Market Application Movement Analysis
5.3. Global Targeted Protein Degradation Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Drug Discovery
- 5.4.1. Drug Discovery market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Therapy Development
- 5.5.1. Therapy Development market estimates and forecasts 2018 to 2030 (USD Million)
- 5.5.2. Cancer
  - 5.5.2.1. Cancer market estimates and forecasts 2018 to 2030 (USD Million)
- 5.5.3. Neurology
  - 5.5.3.1. Neurology market estimates and forecasts 2018 to 2030 (USD Million)
- 5.5.4. Infectious Diseases
  - 5.5.4.1. Infectious Diseases market estimates and forecasts 2018 to 2030 (USD Million)
- 5.5.5. Cardiovascular Diseases
  - 5.5.5.1. Cardiovascular Diseases market estimates and forecasts 2018 to 2030 (USD Million)
- 5.5.6. Others
  - 5.5.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Targeted Protein Degradation Market: End Use Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Global Targeted Protein Degradation Market End-Use Movement Analysis
6.3. Global Targeted Protein Degradation Market Size & Trend Analysis, by End-Use, 2018 to 2030 (USD Million)
6.4. Pharmaceutical & Biotechnology Companies
- 6.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Academic & Research Institutes
- 6.5.1. Academic & Research Institutes market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Hospitals & Clinical Laboratories
- 6.6.1. Hospitals & Clinical Laboratories market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Targeted Protein Degradation Market: Regional Estimates & Trend Analysis

7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.4. North America
- 7.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.2. U.S.
  - 7.4.2.1. Key country dynamics
  - 7.4.2.2. Competitive scenario
  - 7.4.2.3. Regulatory framework
  - 7.4.2.4. Target disease prevalence
  - 7.4.2.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.3. Canada
  - 7.4.3.1. Key country dynamics
  - 7.4.3.2. Competitive scenario
  - 7.4.3.3. Regulatory framework
  - 7.4.3.4. Target disease prevalence
  - 7.4.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.4. Mexico
  - 7.4.4.1. Key country dynamics
  - 7.4.4.2. Competitive scenario
  - 7.4.4.3. Regulatory framework
  - 7.4.4.4. Target disease prevalence
  - 7.4.4.5. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Europe
- 7.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.2. UK
  - 7.5.2.1. Key country dynamics
  - 7.5.2.2. Competitive scenario
  - 7.5.2.3. Regulatory framework
  - 7.5.2.4. Target disease prevalence
  - 7.5.2.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.3. Germany
  - 7.5.3.1. Key country dynamics
  - 7.5.3.2. Competitive scenario
  - 7.5.3.3. Regulatory framework
  - 7.5.3.4. Target disease prevalence
  - 7.5.3.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.4. France
  - 7.5.4.1. Key country dynamics
  - 7.5.4.2. Competitive scenario
  - 7.5.4.3. Regulatory framework
  - 7.5.4.4. Target disease prevalence
  - 7.5.4.5. France market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.5. Italy
  - 7.5.5.1. Key country dynamics
  - 7.5.5.2. Competitive scenario
  - 7.5.5.3. Regulatory framework
  - 7.5.5.4. Target disease prevalence
  - 7.5.5.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.6. Spain
  - 7.5.6.1. Key country dynamics
  - 7.5.6.2. Competitive scenario
  - 7.5.6.3. Regulatory framework
  - 7.5.6.4. Target disease prevalence
  - 7.5.6.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.7. Norway
  - 7.5.7.1. Key country dynamics
  - 7.5.7.2. Competitive scenario
  - 7.5.7.3. Regulatory framework
  - 7.5.7.4. Target disease prevalence
  - 7.5.7.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.8. Sweden
  - 7.5.8.1. Key country dynamics
  - 7.5.8.2. Competitive scenario
  - 7.5.8.3. Regulatory framework
  - 7.5.8.4. Target disease prevalence
  - 7.5.8.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.9. Denmark
  - 7.5.9.1. Key country dynamics
  - 7.5.9.2. Competitive scenario
  - 7.5.9.3. Regulatory framework
  - 7.5.9.4. Target disease prevalence
  - 7.5.9.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Asia Pacific
- 7.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.2. Japan
  - 7.6.2.1. Key country dynamics
  - 7.6.2.2. Competitive scenario
  - 7.6.2.3. Regulatory framework
  - 7.6.2.4. Target disease prevalence
  - 7.6.2.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.3. China
  - 7.6.3.1. Key country dynamics
  - 7.6.3.2. Competitive scenario
  - 7.6.3.3. Regulatory framework
  - 7.6.3.4. Target disease prevalence
  - 7.6.3.5. China market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.4. India
  - 7.6.4.1. Key country dynamics
  - 7.6.4.2. Competitive scenario
  - 7.6.4.3. Regulatory framework
  - 7.6.4.4. Target disease prevalence
  - 7.6.4.5. India market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.5. Australia
  - 7.6.5.1. Key country dynamics
  - 7.6.5.2. Competitive scenario
  - 7.6.5.3. Regulatory framework
  - 7.6.5.4. Target disease prevalence
  - 7.6.5.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.6. South Korea
  - 7.6.6.1. Key country dynamics
  - 7.6.6.2. Competitive scenario
  - 7.6.6.3. Regulatory framework
  - 7.6.6.4. Target disease prevalence
  - 7.6.6.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.7. Thailand
  - 7.6.7.1. Key country dynamics
  - 7.6.7.2. Competitive scenario
  - 7.6.7.3. Target disease prevalence
  - 7.6.7.4. Regulatory framework
  - 7.6.7.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Latin America
- 7.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.2. Brazil
  - 7.7.2.1. Key country dynamics
  - 7.7.2.2. Competitive scenario
  - 7.7.2.3. Regulatory framework
  - 7.7.2.4. Target disease prevalence
  - 7.7.2.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.3. Argentina
  - 7.7.3.1. Key country dynamics
  - 7.7.3.2. Competitive scenario
  - 7.7.3.3. Regulatory framework
  - 7.7.3.4. Target disease prevalence
  - 7.7.3.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.8. MEA
- 7.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
- 7.8.2. South Africa
  - 7.8.2.1. Key country dynamics
  - 7.8.2.2. Competitive scenario
  - 7.8.2.3. Regulatory framework
  - 7.8.2.4. Target disease prevalence
  - 7.8.2.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 7.8.3. Saudi Arabia
  - 7.8.3.1. Key country dynamics
  - 7.8.3.2. Competitive scenario
  - 7.8.3.3. Regulatory framework
  - 7.8.3.4. Target disease prevalence
  - 7.8.3.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.8.4. UAE
  - 7.8.4.1. Key country dynamics
  - 7.8.4.2. Competitive scenario
  - 7.8.4.3. Regulatory framework
  - 7.8.4.4. Target disease prevalence
  - 7.8.4.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 7.8.5. Kuwait
  - 7.8.5.1. Key country dynamics
  - 7.8.5.2. Competitive scenario
  - 7.8.5.3. Regulatory framework
  - 7.8.5.4. Target disease prevalence
  - 7.8.5.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

8.1. Company/Competition Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2023
8.4. Company Profiles/Listing
- 8.4.1. Bayer AG
  - 8.4.1.1. Company overview
  - 8.4.1.2. Financial performance
  - 8.4.1.3. Type benchmarking
  - 8.4.1.4. Strategic initiatives
- 8.4.2. Bio-Techne
  - 8.4.2.1. Company overview
  - 8.4.2.2. Financial performance
  - 8.4.2.3. Type benchmarking
  - 8.4.2.4. Strategic initiatives
- 8.4.3. BOC Sciences
  - 8.4.3.1. Company overview
  - 8.4.3.2. Financial performance
  - 8.4.3.3. Type benchmarking
  - 8.4.3.4. Strategic initiatives
- 8.4.4. BPS Bioscience, Inc.
  - 8.4.4.1. Company overview
  - 8.4.4.2. Financial performance
  - 8.4.4.3. Type benchmarking
  - 8.4.4.4. Strategic initiatives
- 8.4.5. BroadPharm
  - 8.4.5.1. Company overview
  - 8.4.5.2. Financial performance
  - 8.4.5.3. Type benchmarking
  - 8.4.5.4. Strategic initiatives
- 8.4.6. LifeSensors Inc.
  - 8.4.6.1. Company overview
  - 8.4.6.2. Financial performance
  - 8.4.6.3. Type benchmarking
  - 8.4.6.4. Strategic initiatives
- 8.4.7. MedChemExpress.
  - 8.4.7.1. Company overview
  - 8.4.7.2. Financial performance
  - 8.4.7.3. Type benchmarking
  - 8.4.7.4. Strategic initiatives
- 8.4.8. Merck KGaA
  - 8.4.8.1. Company overview
  - 8.4.8.2. Financial performance
  - 8.4.8.3. Type benchmarking
  - 8.4.8.4. Strategic initiatives
- 8.4.9. Promega Corporation
  - 8.4.9.1. Company overview
  - 8.4.9.2. Financial performance
  - 8.4.9.3. Type benchmarking
  - 8.4.9.4. Strategic initiatives
- 8.4.10. Thermo Fisher Scientific, Inc.
  - 8.4.10.1. Company overview
  - 8.4.10.2. Financial performance
  - 8.4.10.3. Type benchmarking
  - 8.4.10.4. Strategic initiatives

Product Code: GVR-4-68040-351-3

List of Tables

Table 1 List of abbreviation
Table 2 Global Targeted protein degradation market, by region, 2018 - 2030 (USD Million)
Table 3 Global Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
Table 4 Global Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
Table 5 Global Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
Table 6 North America Targeted protein degradation market, by country, 2018 - 2030 (USD Million)
Table 7 North America Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
Table 8 North America Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
Table 9 North America Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
Table 10 U.S. Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
Table 11 U.S. Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
Table 12 U.S. Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
Table 13 Canada Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
Table 14 Canada Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
Table 15 Canada Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
Table 16 Mexico Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
Table 17 Mexico Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
Table 18 Mexico Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
Table 19 Europe Targeted protein degradation market, by country, 2018 - 2030 (USD Million)
Table 20 Europe Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
Table 21 Europe Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
Table 22 Europe Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
Table 23 Germany Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
Table 24 Germany Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
Table 25 Germany Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
Table 26 UK Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
Table 27 UK Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
Table 28 UK Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
Table 29 France Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
Table 30 France Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
Table 31 France Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
Table 32 Italy Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
Table 33 Italy Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
Table 34 Italy Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
Table 35 Spain Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
Table 36 Spain Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
Table 37 Spain Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
Table 38 Denmark Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
Table 39 Denmark Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
Table 40 Denmark Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
Table 41 Sweden Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
Table 42 Sweden Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
Table 43 Sweden Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
Table 44 Norway Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
Table 45 Norway Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
Table 46 Norway Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
Table 47 Asia Pacific Targeted protein degradation market, by country, 2018 - 2030 (USD Million)
Table 48 Asia Pacific Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
Table 49 Asia Pacific Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
Table 50 Asia Pacific Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
Table 51 China Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
Table 52 China Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
Table 53 China Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
Table 54 Japan Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
Table 55 Japan Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
Table 56 Japan Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
Table 57 India Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
Table 58 India Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
Table 59 India Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
Table 60 South Korea Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
Table 61 South Korea Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
Table 62 South Korea Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
Table 63 Australia Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
Table 64 Australia Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
Table 65 Australia Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
Table 66 Thailand Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
Table 67 Thailand Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
Table 68 Thailand Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
Table 69 Latin America Targeted protein degradation market, by country, 2018 - 2030 (USD Million)
Table 70 Latin America Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
Table 71 Latin America Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
Table 72 Latin America Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
Table 73 Brazil Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
Table 74 Brazil Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
Table 75 Brazil Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
Table 76 Argentina Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
Table 77 Argentina Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
Table 78 Argentina Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
Table 79 MEA Targeted protein degradation market, by country, 2018 - 2030 (USD Million)
Table 80 MEA Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
Table 81 MEA Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
Table 82 MEA Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
Table 83 South Africa Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
Table 84 South Africa Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
Table 85 South Africa Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
Table 89 UAE Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
Table 90 UAE Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
Table 91 UAE Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)
Table 92 Kuwait Targeted protein degradation market, by type, 2018 - 2030 (USD Million)
Table 93 Kuwait Targeted protein degradation market, by application, 2018 - 2030 (USD Million)
Table 94 Kuwait Targeted protein degradation market, by End-Use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Market formulation & validation
Fig. 4 Targeted Protein Degradation market: Market outlook
Fig. 5 Targeted Protein Degradation market: Segment outlook
Fig. 6 Targeted Protein Degradation market: Competitive landscape outlook
Fig. 7 Parent market outlook
Fig. 8 Targeted Protein Degradation market driver impact
Fig. 9 Targeted Protein Degradation market restraint impact
Fig. 10 Targeted Protein Degradation market: Type outlook and key takeaways
Fig. 11 Targeted Protein Degradation market: Type movement analysis
Fig. 12 PROTAC market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 13 Molecular Glues market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 14 LYTACs market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 15 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 16 Targeted Protein Degradation market: Application outlook and key takeaways
Fig. 17 Targeted Protein Degradation market: Application movement analysis
Fig. 18 Drug Discovery market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Therapy Development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Cancer market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Neurology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Infectious Diseases market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Cardiovascular Diseases market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Targeted Protein Degradation market: End-Use outlook and key takeaways
Fig. 26 Targeted Protein Degradation market: End-Use movement analysis
Fig. 27 Pharmaceutical & biotechnology companies market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 28 Academic & Research Institutes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Hospitals & Clinical Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Global Targeted Protein Degradation market: Regional outlook and key takeaways
Fig. 32 Global Targeted Protein Degradation market: Regional movement analysis
Fig. 33 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Key country dynamics
Fig. 35 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Target Disease Prevalence
Fig. 37 Key country dynamics
Fig. 38 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Target Disease Prevalence
Fig. 40 Key country dynamics
Fig. 41 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Target Disease Prevalence
Fig. 43 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Key country dynamics
Fig. 45 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Target Disease Prevalence
Fig. 47 Key country dynamics
Fig. 48 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Target Disease Prevalence
Fig. 50 Key country dynamics
Fig. 51 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Target Disease Prevalence
Fig. 53 Key country dynamics
Fig. 54 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Target Disease Prevalence
Fig. 56 Key country dynamics
Fig. 57 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Target Disease Prevalence
Fig. 59 Key country dynamics
Fig. 60 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Target Disease Prevalence
Fig. 62 Key country dynamics
Fig. 63 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Target Disease Prevalence
Fig. 65 Key country dynamics
Fig. 66 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Target Disease Prevalence
Fig. 68 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 Key country dynamics
Fig. 70 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Target Disease Prevalence
Fig. 72 Key country dynamics
Fig. 73 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 Target Disease Prevalence
Fig. 75 Key country dynamics
Fig. 76 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 77 Target Disease Prevalence
Fig. 78 Key country dynamics
Fig. 79 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 80 Target Disease Prevalence
Fig. 81 Key country dynamics
Fig. 82 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 83 Target Disease Prevalence
Fig. 84 Key country dynamics
Fig. 85 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 86 Target Disease Prevalence
Fig. 87 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 88 Key country dynamics
Fig. 89 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 90 Target Disease Prevalence
Fig. 91 Key country dynamics
Fig. 92 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 93 Target Disease Prevalence
Fig. 94 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 95 Key country dynamics
Fig. 96 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 97 Target Disease Prevalence
Fig. 98 Key country dynamics
Fig. 99 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 100 Target Disease Prevalence
Fig. 101 Key country dynamics
Fig. 102 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 103 Target Disease Prevalence
Fig. 104 Key country dynamics
Fig. 105 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 106 Target Disease Prevalence